No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 3,795 | 8,004 | 7,172 | 5,406 | 6,403 | 5,844 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 231 | 2,402 | 505 | 19 | 213 | 88 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Operating both domestically within China and across global markets, Jiangsu SOPO Chemical Co. Ltd. specializes in the production and distribution of various chemical products. Its product portfolio includes acetic acid and its derivatives, which find applications in sectors such as dyes, textile printing, film production, solvents, pharmaceuticals, and pesticides. Additionally, the company supplies ethyl acetate, a vital organic chemical raw material. This compound is utilized in the manufacturing of paints, adhesives, ethyl celluloses, synthetic leathers, linoleum colorants, and artificial fibers; it also functions as a bonding agent in printing inks and as a crucial process solvent for organic chemical synthesis. Another offering is methyl alcohol, essential for the chemical and plastics industries, among others. Furthermore, Jiangsu SOPO produces ADC foaming agents, instrumental in the frothing processes for materials like EVA, PE, natural rubber, and PVC + NBR blends. The company's range extends to sulfuric acid products, serving chemical manufacturing, pharmaceuticals, and oil refining sectors. Other key chemicals include chlorinated benzene, fatty alcohol, and chloroacetic acid. Established in 1996, the company maintains its headquarters in Zhenjiang, located in the People's Republic of China.
Similar companies
- Jiangsu Zhengdan Chemical Industry Co., Ltd.
- Anhui Guofeng New Materials Co., Ltd.
- Hangzhou Greenda Electronic Materials Co., Ltd.
- ISU Specialty Chemical Co., Ltd.
- Polyrocks Chemical Co.,LTD
- Kazan Public Joint Stock Company Organichesky sintez
- Xinjiang Tianye Co.,Ltd.
- Xiangtan Electrochemical Scientific Co.,Ltd
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Jiangsu SOPO Chemical Co. Ltd. (600746.SS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Operating both domestically within China and across global markets, Jiangsu SOPO Chemical Co. Ltd. specializes in the production and distribution of various chemical products. Its product portfolio includes acetic acid and its derivatives, which find applications in sectors such as dyes, textile printing, film production, solvents, pharmaceuticals, and pesticides. Additionally, the company supplies ethyl acetate, a vital organic chemical raw material. This compound is utilized in the manufacturing of paints, adhesives, ethyl celluloses, synthetic leathers, linoleum colorants, and artificial fibers; it also functions as a bonding agent in printing inks and as a crucial process solvent for organic chemical synthesis. Another offering is methyl alcohol, essential for the chemical and plastics industries, among others. Furthermore, Jiangsu SOPO produces ADC foaming agents, instrumental in the frothing processes for materials like EVA, PE, natural rubber, and PVC + NBR blends. The company's range extends to sulfuric acid products, serving chemical manufacturing, pharmaceuticals, and oil refining sectors. Other key chemicals include chlorinated benzene, fatty alcohol, and chloroacetic acid. Established in 1996, the company maintains its headquarters in Zhenjiang, located in the People's Republic of China.
- Jiangsu Zhengdan Chemical Industry Co., Ltd.
- Anhui Guofeng New Materials Co., Ltd.
- Hangzhou Greenda Electronic Materials Co., Ltd.
- ISU Specialty Chemical Co., Ltd.
- Polyrocks Chemical Co.,LTD
- Kazan Public Joint Stock Company Organichesky sintez
- Xinjiang Tianye Co.,Ltd.
- Xiangtan Electrochemical Scientific Co.,Ltd